Propanc Biopharma announces plan to acquire $100 million of Ethereum

* Propanc Biopharma (NASDAQ:PPCB [https://seekingalpha.com/symbol/PPCB]) announced on Tuesday a plan to acquire $100 million of Ethereum over the next 12 months.
* "The strategic purchase of Ethereum provides a significant opportunity to diversify assets, realize potential value, address current cash flow needs of the Company during the pre-revenue stage and help to accelerate future revenue growth potential by investing into the company’s core assets to commercialization, whilst also identifying new opportunities to expand its IP portfolio through acquisition," stated the company in its press release.
* “These returns have captured the Board’s attention and consequently, we plan to be among the few biotechnology companies leveraging cryptocurrency to enhance shareholder returns whilst aggressively developing our existing drug pipeline and pursuing an accretive acquisition strategy,” said James Nathanielsz, Propanc’s Chief Executive Officer.
* PPCB is +0.331126% to $3.03
* Source: Press Release [https://seekingalpha.com/pr/20217628-propanc-biopharma-announces-plan-to-acquire-100-million-of-ethereum]

MORE ON PROPANC BIOPHARMA, INC.

* Financial information for Propanc Biopharma, Inc. [https://seekingalpha.com/symbol/PPCB/income-statement]